Moreover, overexpression of IL-6 results in over-activated receptor signaling that contributes to the constitutive activation of STAT3 that has been observed in advanced stages of CTCL [26]. Here, STAT3 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.